ARTICLE SUMMARY:
The Medtronic/Covidien deal is the biggest merger in medical device history, with implications far beyond the size of the combined companies. In Part II of our interview with Medtronic’s Geoff Martha, we discuss the impact the merger could have on Medtronic’s business strategies going forward and what that signals for the medical device industry as a whole.
In the simplest terms, the merger of Medtronic Inc. and Covidien PLC creates a therapeutic device company of unparalleled size and scope, with market-leading positions in dozens of key clinical areas and technology spaces.
